To the Editor We read with great interest the systematic review on quality indicators for end-of-life cancer care by Henson et al1 because our team also has experience with these methods. While creating a comprehensive list of palliative care quality indicators for advanced cancer is a useful endeavor, we are concerned about measures missed in the review, the criteria used to create the shortlist, and the face validity of the shortlist.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
O’Hanlon CE, Walling AM, Lindvall C. Shortlist of Quality Indicators for End-of-Life Cancer Care. JAMA Oncol. 2020;6(7):1118–1119. doi:10.1001/jamaoncol.2020.1159
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: